Also known as saw palmetto, this homeopathic remedy is prescribed for prostate problems ranging from BPH to prostate cancer. Homeopaths may prescribe this remedy for men with BPH who have little or no sexual desire, who experience painful erections, whose genital region is cold to the touch, and who may have testicular atrophy.
A study conducted at Georgetown University Medical Center looked at the antiproliferative effects of homeopathic remedies of sabal serrulata, thuja occidentalis, and conium maculatum in mouse xenografts and human prostate cancer and breast cancer cells. (Xenografts are skin grafts taken from one species and applied to another. In this case, the grafts came from human prostate tumors and were grafted to nude mice.)
Treatment with sabal serrulata on two different cell lines of prostate cancer cells resulted in a 23 and 33 percent decrease in proliferation of the cells in the two groups, but no effect on the breast cancer cells. The mice that were treated with sabal serrulata showed a significant reduction in the size of the prostate tumor xenograft when compared with mice that were not treated with the homeopathic remedy. From the results of this study, the researchers concluded that sabal serrulata should be investigated further as a homeopathic remedy for prostate cancer. (MacLaughlin 2006)
A 2006 study published in Integrative Cancer Therapy did not find the homeopathic remedies carcinosin, sabal, conium maculatum, or thuja to be effective against prostate cancer cell growth or gene expression in mice. (Thangapazham 2006)
If you are interested in taking sabal serrulata, consult a professional homeopath.
MacLaughlin BW, Gutsmuths B, Pretner E, Jonas WB, Ives J, Kulawardane DV, Amri H. Effects of homeopathic preparations on human prostate cancer growth in cellular and animal models. Integr Cancer Ther 2006 Dec; 5(4): 362-72.
Thangapazham RL, Gaddipati JP, Rajeshkumar NV, Sharma A et al. Homeopathic medicines do not alter growth and gene expression in prostate and breast cancer cells in vitro. Integr Cancer Ther 2006 Dec; 5(4): 356-61